-
公开(公告)号:EP2036561B1
公开(公告)日:2017-05-10
申请号:EP07767849.8
申请日:2007-06-22
IPC分类号: A61K31/519 , A61K31/426 , A61K31/444 , A61K31/4745 , A61P19/06 , A61P35/00 , C07D277/20 , C07D277/56 , C07D401/14 , C07D487/04 , C07D513/04
CPC分类号: C07D513/04 , A61K31/426 , A61K31/444 , A61K31/4745 , A61K31/519 , A61K45/06 , C07D277/20 , C07D277/56 , C07D401/14 , C07D487/04
-
公开(公告)号:EP3219319A1
公开(公告)日:2017-09-20
申请号:EP17169940.8
申请日:2007-06-22
IPC分类号: A61K31/519 , A61K31/426 , A61K31/444 , A61K31/4745 , A61P35/00 , C07D277/20 , C07D277/56 , C07D401/14 , C07D487/04 , C07D513/04
CPC分类号: C07D513/04 , A61K31/426 , A61K31/444 , A61K31/4745 , A61K31/519 , A61K45/06 , C07D277/20 , C07D277/56 , C07D401/14 , C07D487/04
摘要: An agent comprising, as an active ingredient, a xanthine oxidase inhibitor such as 2-[3-cyano-4-(4-fluorophenoxy)phenyl]-4-hydroxythiazolo[5,4-d]pyrimidine potassium salt, 2-[3-cyano-4-(4-fluorophenoxy)phenyl]thiazolo[5,4-d]pyrimidine, 2-(3-cyano-4-phenoxyphenyl)-4-hydroxythiazolo[5,4-d]pyrimidine, 2-(3-cyano-4-phenoxyphenyl)-4-hydroxythiazolo[5,4-d]pyrimidine potassium salt, 2-(3-cyano-4-phenoxyphenyl)thiazolo[5,4-d]pyrimidine, TMX-67, and FYX-051, which can be used as an agent for overcoming anti-cancer agent resistance.
摘要翻译: 含有黄嘌呤氧化酶抑制剂如2- [3-氰基-4-(4-氟苯氧基)苯基] -4-羟基噻唑并[5,4-d]嘧啶钾盐,2- [3 (4-氟苯氧基)苯基]噻唑并[5,4-d]嘧啶,2-(3-氰基-4-苯氧基苯基)-4-羟基噻唑并[5,4-d]嘧啶,2- (3-氰基-4-苯氧基苯基)噻唑并[5,4-d]嘧啶,TMX-67和FYX- 051,它可以用作克服抗癌剂抗性的药物。
-
公开(公告)号:EP2036561A1
公开(公告)日:2009-03-18
申请号:EP07767849.8
申请日:2007-06-22
IPC分类号: A61K31/519 , A61K31/426 , A61K31/444 , A61K31/4745 , A61K45/00 , A61P19/06 , A61P35/00 , A61P43/00 , C07D277/20 , C07D277/56 , C07D401/14 , C07D487/04 , C07D513/04
CPC分类号: C07D513/04 , A61K31/426 , A61K31/444 , A61K31/4745 , A61K31/519 , A61K45/06 , C07D277/20 , C07D277/56 , C07D401/14 , C07D487/04
摘要: An agent comprising, as an active ingredient, a xanthine oxidase inhibitor such as 2-[3-cyano-4-(4-fluorophenoxy)phenyl]-4-hydroxythiazolo[5,4-d]pyrimidine potassium salt, 2-[3-cyano-4-(4-fluorophenoxy)phenyl]thiazolo[5,4-d]pyrimidine, 2-(3-cyano-4-phenoxyphenyl)-4-hydroxythiazolo[5,4-d]pyrimidine, 2-(3-cyano-4-phenoxyphenyl)-4-hydroxythiazolo[5,4-d]pyrimidine potassium salt, 2-(3-cyano-4-phenoxyphenyl)thiazolo[5,4-d]pyrimidine, TMX-67, and FYX-051, which can be used as an agent for overcoming anti-cancer agent resistance.
-
-